Venus Remedies Ltd
NSE:VENUSREM

Watchlist Manager
Venus Remedies Ltd Logo
Venus Remedies Ltd
NSE:VENUSREM
Watchlist
Price: 729.35 INR -1.94%
Market Cap: 9.8B INR

Profitability Summary

Venus Remedies Ltd's profitability score is 52/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score
52/100
Profitability
Score

Margins

Earnings Waterfall
Venus Remedies Ltd

Margins Comparison
Venus Remedies Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Venus Remedies Ltd
NSE:VENUSREM
9.8B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.7B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
220.9B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
271.6B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
148.4B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Venus Remedies Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Venus Remedies Ltd
NSE:VENUSREM
9.8B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
220.9B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
271.6B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
148.4B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Venus Remedies Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate